TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2535294
log Bayes Factor = 140.759
Chromosome 6   position 31,062,133  (GRCh37) Explore rs2535294 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E07 Other disorders of thyroid
0.000 0.001 0.999
E07.9 Disorder of thyroid, unspecified
0.000 0.001 0.999
L40 Psoriasis
0.998 0.002 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.008 0.992
L40.5 Arthropathic psoriasis
0.982 0.018 0.000
L40.0 Psoriasis vulgaris
0.980 0.020 0.000
E83.1 Disorders of iron metabolism
0.932 0.068 0.000
E10.9 Without complications
0.000 0.078 0.922
C61 Malignant neoplasm of prostate
0.911 0.089 0.000
E10 Insulin-dependent diabetes mellitus
0.000 0.090 0.910
E10-E14 Diabetes mellitus
0.000 0.113 0.887
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.116 0.884
E10.3 With ophthalmic complications
0.000 0.132 0.868
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.144 0.856
E03.8 Other specified hypothyroidism
0.000 0.180 0.820
L40.4 Guttate psoriasis
0.814 0.186 0.000
K90 Intestinal malabsorption
0.000 0.190 0.810
E10.2 With renal complications
0.000 0.207 0.793
L40.3 Pustulosis palmaris et plantaris
0.787 0.213 0.000
E06 Thyroiditis
0.000 0.265 0.735
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.267 0.733
L40.1 Generalised pustular psoriasis
0.732 0.268 0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.270 0.730
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E07.1 Dyshormogenetic goitre
0.000 0.283 0.716
E07.0 Hypersecretion of calcitonin
0.000 0.283 0.716
L40.2 Acrodermatitis continua
0.715 0.284 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.286 0.714
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.302 0.698
E20-E35 Disorders of other endocrine glands
0.000 0.303 0.697
E07.8 Other specified disorders of thyroid
0.000 0.312 0.688
E28 Ovarian dysfunction
0.000 0.328 0.672
K90.9 Intestinal malabsorption, unspecified
0.000 0.329 0.671
E05.8 Other thyrotoxicosis
0.000 0.330 0.670
E14 Unspecified diabetes mellitus
0.000 0.330 0.670
L40.8 Other psoriasis
0.667 0.333 0.000
E10.4 With neurological complications
0.000 0.338 0.662
E10.7 With multiple complications
0.000 0.340 0.659
E10.0 With coma
0.000 0.354 0.646
E28.3 Primary ovarian failure
0.000 0.363 0.637
E12 Malnutrition-related diabetes mellitus
0.000 0.364 0.636
K90.8 Other intestinal malabsorption
0.000 0.385 0.615
E06.3 Autoimmune thyroiditis
0.000 0.388 0.612
E14.3 With ophthalmic complications
0.000 0.389 0.611
E03.1 Congenital hypothyroidism without goitre
0.000 0.393 0.606
E24 Cushing's syndrome
0.000 0.401 0.599
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.401 0.599
E23 Hypofunction and other disorders of pituitary gland
0.000 0.402 0.598
E40-E46 Malnutrition
0.000 0.419 0.581
K90.3 Pancreatic steatorrhoea
0.000 0.419 0.581
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.419 0.581
K90.1 Tropical sprue
0.000 0.419 0.581
E06.5 Other chronic thyroiditis
0.000 0.427 0.573
E28.2 Polycystic ovarian syndrome
0.000 0.431 0.569
E10.8 With unspecified complications
0.000 0.437 0.563
M35.0 Sicca syndrome [Sjogren]
0.000 0.437 0.563
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.449 0.551
E23.2 Diabetes insipidus
0.000 0.450 0.550
E10.6 With other specified complications
0.000 0.452 0.548
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.455 0.545
E13 Other specified diabetes mellitus
0.000 0.463 0.537
E24.2 Drug-induced Cushing's syndrome
0.000 0.465 0.535
E14.5 With peripheral circulatory complications
0.000 0.465 0.535
E06.4 Drug-induced thyroiditis
0.000 0.473 0.527
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.473 0.527
E06.0 Acute thyroiditis
0.000 0.473 0.527
E06.1 Subacute thyroiditis
0.000 0.485 0.515
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E10.1 With ketoacidosis
0.000 0.490 0.510
E31 Polyglandular dysfunction
0.000 0.494 0.506
E21.3 Hyperparathyroidism, unspecified
0.000 0.495 0.505
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.500 0.500
E32 Diseases of thymus
0.000 0.500 0.500
E30 Disorders of puberty, not elsewhere classified
0.000 0.500 0.500
E14.8 With unspecified complications
0.000 0.505 0.494
E28.9 Ovarian dysfunction, unspecified
0.000 0.518 0.482
E28.8 Other ovarian dysfunction
0.000 0.518 0.482
E28.1 Androgen excess
0.000 0.518 0.482
E28.0 Oestrogen excess
0.000 0.518 0.482
E14.7 With multiple complications
0.000 0.519 0.480
E14.0 With coma
0.000 0.519 0.480
E14.6 With other specified complications
0.000 0.522 0.478
E14.1 With ketoacidosis
0.000 0.524 0.476
E23.6 Other disorders of pituitary gland
0.000 0.529 0.471
E14.2 Withrenal complications
0.000 0.536 0.463
E10.5 With peripheral circulatory complications
0.000 0.538 0.462
E12.9 Without complications
0.000 0.544 0.456
E12.8 With unspecified complications
0.000 0.544 0.456
E12.7 With multiple complications
0.000 0.544 0.456
E12.6 With other specified complications
0.000 0.544 0.456
E12.5 With peripheral circulatory complications
0.000 0.544 0.456
E12.4 With neurological complications
0.000 0.544 0.456
E12.3 With ophthalmic complications
0.000 0.544 0.456
E12.2 With renal complications
0.000 0.544 0.456
E12.1 With ketoacidosis
0.000 0.544 0.456
E12.0 With coma
0.000 0.544 0.456
E23.7 Disorder of pituitary gland, unspecified
0.000 0.544 0.456
E20 Hypoparathyroidism
0.000 0.549 0.451
E14.4 With neurological complications
0.000 0.551 0.449
E24.0 Pituitary-dependent Cushing's disease
0.000 0.556 0.443
E25 Adrenogenital disorders
0.000 0.563 0.437
E26 Hyperaldosteronism
0.000 0.569 0.431
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.570 0.430
E24.3 Ectopic ACTH syndrome
0.000 0.570 0.430
E24.1 Nelson's syndrome
0.000 0.570 0.430
E15 Nondiabetic hypoglycaemic coma
0.000 0.570 0.429
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.571 0.429
E23.1 Drug-induced hypopituitarism
0.000 0.571 0.429
E24.8 Other Cushing's syndrome
0.000 0.578 0.422
E13.3 With ophthalmic complications
0.000 0.580 0.420
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.583 0.417
E45 Retarded development following protein-energy malnutrition
0.000 0.583 0.417
E43 Unspecified severe protein-energy malnutrition
0.000 0.583 0.417
E42 Marasmic kwashiorkor
0.000 0.583 0.417
E41 Nutritional marasmus
0.000 0.583 0.417
E40 Kwashiorkor
0.000 0.583 0.417
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.585 0.415
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.589 0.411
E24.9 Cushing's syndrome, unspecified
0.000 0.592 0.407
E29 Testicular dysfunction
0.000 0.596 0.403
E21.2 Other hyperparathyroidism
0.000 0.600 0.400
E16 Other disorders of pancreatic internal secretion
0.000 0.606 0.394
E50-E64 Other nutritional deficiencies
0.000 0.606 0.394
E13.8 With unspecified complications
0.000 0.614 0.385
E13.7 With multiple complications
0.000 0.614 0.385
E13.6 With other specified complications
0.000 0.614 0.385
E13.5 With peripheral circulatory complications
0.000 0.614 0.385
E13.4 With neurological complications
0.000 0.614 0.385
E13.2 With renal complications
0.000 0.614 0.385
E13.1 With ketoacidosis
0.000 0.614 0.385
E13.0 With coma
0.000 0.614 0.385
E21.4 Other specified disorders of parathyroid gland
0.000 0.630 0.370
E31.0 Autoimmune polyglandular failure
0.000 0.631 0.368
E46 Unspecified protein-energy malnutrition
0.000 0.636 0.364
E31.9 Polyglandular dysfunction, unspecified
0.000 0.637 0.363
E31.8 Other polyglandular dysfunction
0.000 0.637 0.363
E31.1 Polyglandular hyperfunction
0.000 0.637 0.363
E30.9 Disorder of puberty, unspecified
0.000 0.641 0.358
E30.8 Other disorders of puberty
0.000 0.641 0.358
E30.1 Precocious puberty
0.000 0.641 0.358
E30.0 Delayed puberty
0.000 0.641 0.358
E32.9 Disease of thymus, unspecified
0.000 0.641 0.358
E32.8 Other diseases of thymus
0.000 0.641 0.358
E32.1 Abscess of thymus
0.000 0.641 0.358
E32.0 Persistent hyperplasia of thymus
0.000 0.641 0.358
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.641 0.358
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.641 0.358
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.641 0.358
E06.9 Thyroiditis, unspecified
0.000 0.653 0.347
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.654 0.346
E22 Hyperfunction of pituitary gland
0.000 0.665 0.335
E20.8 Other hypoparathyroidism
0.000 0.677 0.323
E20.1 Pseudohypoparathyroidism
0.000 0.677 0.323
E20.0 Idiopathic hypoparathyroidism
0.000 0.677 0.323
C83.3 Large cell (diffuse)
0.000 0.677 0.323
E34 Other endocrine disorders
0.001 0.678 0.321
E25.9 Adrenogenital disorder, unspecified
0.000 0.687 0.313
E25.8 Other adrenogenital disorders
0.000 0.687 0.313
C60-C63 Malignant neoplasms of male genital organs
0.313 0.687 0.000
E26.9 Hyperaldosteronism, unspecified
0.000 0.691 0.309
E26.8 Other hyperaldosteronism
0.000 0.691 0.309
E26.1 Secondary hyperaldosteronism
0.000 0.691 0.309
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.700 0.300
E51 Thiamine deficiency
0.000 0.700 0.300
E44.1 Mild protein-energy malnutrition
0.000 0.701 0.299
E44.0 Moderate protein-energy malnutrition
0.000 0.701 0.299
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.702 0.298
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.702 0.298
E56 Other vitamin deficiencies
0.000 0.707 0.293
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.709 0.291
C85.1 B-cell lymphoma, unspecified
0.000 0.709 0.291
E29.8 Other testicular dysfunction
0.000 0.710 0.289
E29.0 Testicular hyperfunction
0.000 0.710 0.289
E65-E68 Obesity and other hyperalimentation
0.000 0.712 0.288
C81 Hodgkin's disease
0.000 0.714 0.286
E58 Dietary calcium deficiency
0.000 0.715 0.284
E29.9 Testicular dysfunction, unspecified
0.000 0.715 0.284
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.717 0.283
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.717 0.283
E16.4 Abnormal secretion of gastrin
0.000 0.717 0.283
E16.3 Increased secretion of glucagon
0.000 0.717 0.283
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.717 0.283
E63 Other nutritional deficiencies
0.000 0.717 0.283
E50 Vitamin A deficiency
0.000 0.717 0.283
E60 Dietary zinc deficiency
0.000 0.717 0.283
E59 Dietary selenium deficiency
0.000 0.717 0.283
E52 Niacin deficiency [pellagra]
0.000 0.717 0.283
E61 Deficiency of other nutrient elements
0.000 0.718 0.282
E20.9 Hypoparathyroidism, unspecified
0.000 0.726 0.274
C81.9 Hodgkin's disease, unspecified
0.000 0.729 0.271
E16.1 Other hypoglycaemia
0.000 0.739 0.261
E34.8 Other specified endocrine disorders
0.000 0.743 0.257
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.746 0.254
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.001 0.750 0.250
L40-L45 Papulosquamous disorders
0.247 0.753 0.000
E34.3 Short stature, not elsewhere classified
0.001 0.756 0.243
C83.7 Burkitt's tumour
0.000 0.757 0.242
C81.2 Mixed cellularity
0.000 0.759 0.241
E54 Ascorbic acid deficiency
0.000 0.759 0.241
E22.8 Other hyperfunction of pituitary gland
0.000 0.759 0.240
E26.0 Primary hyperaldosteronism
0.000 0.760 0.240
C60 Malignant neoplasm of penis
0.240 0.760 0.000
M35 Other systemic involvement of connective tissue
0.000 0.763 0.237
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.763 0.237
E51.2 Wernicke's encephalopathy
0.000 0.768 0.232
E34.5 Androgen resistance syndrome
0.001 0.769 0.230
E34.4 Constitutional tall stature
0.001 0.769 0.230
E34.2 Ectopic hormone secretion, not elsewhere classified
0.001 0.769 0.230
E34.1 Other hypersecretion of intestinal hormones
0.001 0.769 0.230
C81.1 Nodular sclerosis
0.000 0.770 0.230
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.773 0.226
C81.0 Lymphocytic predominance
0.000 0.774 0.226
E61.2 Magnesium deficiency
0.000 0.778 0.222
E56.1 Deficiency of vitamin K
0.000 0.780 0.220
C83.1 Small cleaved cell (diffuse)
0.000 0.784 0.216
C63 Malignant neoplasm of other and unspecified male genital organs
0.216 0.784 0.000
C85.0 Lymphosarcoma
0.000 0.784 0.215
E51.9 Thiamine deficiency, unspecified
0.000 0.785 0.215
E51.8 Other manifestations of thiamine deficiency
0.000 0.785 0.215
E51.1 Beriberi
0.000 0.785 0.215
C83.6 Undifferentiated (diffuse)
0.000 0.786 0.214
C83.4 Immunoblastic (diffuse)
0.000 0.786 0.214
C83.2 Mixed small and large cell (diffuse)
0.000 0.786 0.214
E13.9 Without complications
0.000 0.787 0.213
E27 Other disorders of adrenal gland
0.000 0.787 0.212
C86 Other specified types of T/NK-cell lymphoma
0.000 0.790 0.210
E56.9 Vitamin deficiency, unspecified
0.000 0.790 0.210
E56.8 Deficiency of other vitamins
0.000 0.790 0.210
E56.0 Deficiency of vitamin E
0.000 0.790 0.210
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.790 0.210
K60.2 Anal fissure, unspecified
0.000 0.790 0.210
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.791 0.209
E22.1 Hyperprolactinaemia
0.000 0.791 0.209
E53 Deficiency of other B group vitamins
0.000 0.792 0.208
E67 Other hyperalimentation
0.000 0.793 0.207
E68 Sequelae of hyperalimentation
0.000 0.793 0.207
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.794 0.206
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.795 0.205
C81.3 Lymphocytic depletion
0.000 0.795 0.205
E50.9 Vitamin A deficiency, unspecified
0.000 0.797 0.203
E50.8 Other manifestations of vitamin A deficiency
0.000 0.797 0.203
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.797 0.203
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.797 0.203
E50.5 Vitamin A deficiency with night blindness
0.000 0.797 0.203
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.797 0.203
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.797 0.203
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.797 0.203
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.797 0.203
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.797 0.203
E63.9 Nutritional deficiency, unspecified
0.000 0.797 0.203
E63.8 Other specified nutritional deficiencies
0.000 0.797 0.203
E63.1 Imbalance of constituents of food intake
0.000 0.797 0.203
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.797 0.203
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.797 0.203
E64.8 Sequelae of other nutritional deficiencies
0.000 0.797 0.203
E64.3 Sequelae of rickets
0.000 0.797 0.203
E64.2 Sequelae of vitamin C deficiency
0.000 0.797 0.203
E64.1 Sequelae of vitamin A deficiency
0.000 0.797 0.203
E64.0 Sequelae of protein-energy malnutrition
0.000 0.797 0.203
C93 Monocytic leukaemia
0.000 0.798 0.202
E61.9 Deficiency of nutrient element, unspecified
0.000 0.798 0.202
E61.8 Deficiency of other specified nutrient elements
0.000 0.798 0.202
E61.7 Deficiency of multiple nutrient elements
0.000 0.798 0.202
E61.6 Vanadium deficiency
0.000 0.798 0.202
E61.5 Molybdenum deficiency
0.000 0.798 0.202
E61.4 Chromium deficiency
0.000 0.798 0.202
E61.3 Manganese deficiency
0.000 0.798 0.202
E61.0 Copper deficiency
0.000 0.798 0.202
C83.5 Lymphoblastic (diffuse)
0.000 0.798 0.202
E29.1 Testicular hypofunction
0.000 0.798 0.202
C88 Malignant immunoproliferative diseases
0.000 0.800 0.200
L41 Parapsoriasis
0.197 0.803 0.000
M35.7 Hypermobility syndrome
0.000 0.804 0.196
E23.0 Hypopituitarism
0.000 0.804 0.195
K60 Fissure and fistula of anal and rectal regions
0.000 0.805 0.195
C94 Other leukaemias of specified cell type
0.000 0.805 0.195
E55 Vitamin D deficiency
0.000 0.806 0.194
C95 Leukaemia of unspecified cell type
0.000 0.806 0.193
C81.7 Other Hodgkin's disease
0.000 0.809 0.191
C92 Myeloid leukaemia
0.000 0.812 0.188
C60.9 Penis, unspecified
0.185 0.815 0.000
K60.3 Anal fistula
0.000 0.816 0.184
C60.1 Glans penis
0.183 0.817 0.000
M35.8 Other specified systemic involvement of connective tissue
0.000 0.817 0.183
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.818 0.182
K60.0 Acute anal fissure
0.000 0.818 0.182
M35.2 Behcet's disease
0.000 0.820 0.180
C92.1 Chronic myeloid leukaemia
0.000 0.820 0.180
M35.1 Other overlap syndromes
0.000 0.821 0.179
C62 Malignant neoplasm of testis
0.179 0.821 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.177 0.823 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.823 0.177
L44 Other papulosquamous disorders
0.176 0.824 0.000
E61.1 Iron deficiency
0.000 0.825 0.175
C82.3 Follicular lymphoma grade IIIa
0.000 0.827 0.173
C60.8 Overlapping lesion of penis
0.172 0.828 0.000
C60.2 Body of penis
0.172 0.828 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.828 0.172
M35.9 Systemic involvement of connective tissue, unspecified
0.000 0.830 0.170
M35.6 Relapsing panniculitis [Weber-Christian]
0.000 0.830 0.170
M35.5 Multifocal fibrosclerosis
0.000 0.830 0.170
M35.4 Diffuse (eosinophilic) fasciitis
0.000 0.830 0.170
K60.5 Anorectal fistula
0.000 0.834 0.166
C60.0 Prepuce
0.163 0.837 0.000
E65 Localised adiposity
0.000 0.838 0.161
L41.1 Pityriasis lichenoides chronica
0.161 0.839 0.000
E27.1 Primary adrenocortical insufficiency
0.000 0.840 0.160
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.842 0.158
E21.0 Primary hyperparathyroidism
0.000 0.842 0.158
L42 Pityriasis rosea
0.155 0.845 0.000
C63.9 Male genital organ, unspecified
0.155 0.845 0.000
C63.8 Overlapping lesion of male genital organs
0.155 0.845 0.000
C63.7 Other specified male genital organs
0.155 0.845 0.000
C63.1 Spermatic cord
0.155 0.845 0.000
C63.0 Epididymis
0.155 0.845 0.000
E27.5 Adrenomedullary hyperfunction
0.000 0.847 0.152
E27.0 Other adrenocortical overactivity
0.000 0.847 0.152
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.848 0.152
H00.1 Chalazion
0.152 0.848 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.849 0.151
C86.4 Blastic NK-cell lymphoma
0.000 0.849 0.151
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.849 0.151
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.849 0.151
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.849 0.151
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.849 0.151
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.850 0.150
C96.8 Histiocytic sarcoma
0.000 0.850 0.150
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.850 0.150
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.850 0.150
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.850 0.150
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.850 0.150
C96.3 True histiocytic lymphoma
0.000 0.850 0.150
C96.2 Malignant mast cell tumour
0.000 0.850 0.150
C96.1 Malignant histiocytosis
0.000 0.850 0.150
C96.0 Letterer-Siwe disease
0.000 0.850 0.150
C95.9 Leukaemia, unspecified
0.000 0.850 0.150
C82.2 Large cell, follicular
0.000 0.850 0.150
K60.4 Rectal fistula
0.000 0.850 0.150
E53.1 Pyridoxine deficiency
0.000 0.851 0.149
E53.0 Riboflavin deficiency
0.000 0.851 0.149
E67.8 Other specified hyperalimentation
0.000 0.851 0.148
E67.3 Hypervitaminosis D
0.000 0.851 0.148
E67.2 Megavitamin-B6 syndrome
0.000 0.851 0.148
E67.1 Hypercarotenaemia
0.000 0.851 0.148
E67.0 Hypervitaminosis A
0.000 0.851 0.148
C82.6 Cutaneous follicle centre lymphoma
0.000 0.852 0.148
C82.5 Diffuse follicle centre lymphoma
0.000 0.852 0.148
C63.2 Scrotum
0.146 0.854 0.000
C93.9 Monocytic leukaemia, unspecified
0.000 0.855 0.145
C93.7 Other monocytic leukaemia
0.000 0.855 0.145
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.855 0.145
C93.2 Subacute monocytic leukaemia
0.000 0.855 0.145
C93.0 Acute monocytic leukaemia
0.000 0.855 0.145
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.855 0.145
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.857 0.143
C88.7 Other malignant immunoproliferative diseases
0.000 0.857 0.143
C88.3 Immunoproliferative small intestinal disease
0.000 0.857 0.143
C88.2 Gamma heavy chain disease
0.000 0.857 0.143
C88.1 Alpha heavy chain disease
0.000 0.857 0.143
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.857 0.143
E27.9 Disorder of adrenal gland, unspecified
0.000 0.858 0.141
L41.9 Parapsoriasis, unspecified
0.141 0.859 0.000
L41.8 Other parapsoriasis
0.141 0.859 0.000
L41.5 Retiform parapsoriasis
0.141 0.859 0.000
L41.4 Large plaque parapsoriasis
0.141 0.859 0.000
L41.3 Small plaque parapsoriasis
0.141 0.859 0.000
L41.2 Lymphomatoid papulosis
0.141 0.859 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.141 0.859 0.000
C94.7 Other specified leukaemias
0.000 0.860 0.140
C94.5 Acute myelofibrosis
0.000 0.860 0.140
C94.4 Acute panmyelosis
0.000 0.860 0.140
C94.3 Mast cell leukaemia
0.000 0.860 0.140
C94.2 Acute megakaryoblastic leukaemia
0.000 0.860 0.140
C94.1 Chronic erythraemia
0.000 0.860 0.140
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.860 0.140
E55.0 Rickets, active
0.000 0.860 0.139
E53.9 Vitamin B deficiency, unspecified
0.000 0.861 0.139
C95.7 Other leukaemia of unspecified cell type
0.000 0.861 0.139
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.861 0.139
C93.1 Chronic monocytic leukaemia
0.000 0.861 0.138
E22.0 Acromegaly and pituitary gigantism
0.000 0.862 0.137
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.864 0.136
C84.0 Mycosis fungoides
0.000 0.865 0.135
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.865 0.135
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.865 0.135
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.865 0.135
C92.3 Myeloid sarcoma
0.000 0.865 0.135
C92.2 Subacute myeloid leukaemia
0.000 0.865 0.135
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.867 0.133
C92.5 Acute myelomonocytic leukaemia
0.000 0.868 0.132
C84.5 Other and unspecified T-cell lymphomas
0.000 0.869 0.131
C82.4 Follicular lymphoma grade IIIb
0.000 0.869 0.131
C62.1 Descended testis
0.129 0.871 0.000
C62.0 Undescended testis
0.128 0.872 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.873 0.127
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.873 0.127
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.873 0.127
C84.3 Lymphoepithelioid lymphoma
0.000 0.873 0.127
C84.2 T-zone lymphoma
0.000 0.873 0.127
C84.1 Sezary's diease
0.000 0.873 0.127
L44.9 Papulosquamous disorder, unspecified
0.126 0.873 0.000
L44.8 Other specified papulosquamous disorders
0.126 0.873 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.126 0.873 0.000
L44.3 Lichen ruber moniliformis
0.126 0.873 0.000
L44.2 Lichen striatus
0.126 0.873 0.000
L44.1 Lichen nitidus
0.126 0.873 0.000
E34.0 Carcinoid syndrome
0.001 0.874 0.125
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.874 0.126
L44.0 Pityriasis rubra pilaris
0.126 0.874 0.000
C91 Lymphoid leukaemia
0.000 0.875 0.125
C82.0 Small cleaved cell, follicular
0.000 0.875 0.125
M35.99 Systemic involvement of connective tissue, unspecified, Site unspecified
0.000 0.878 0.122
C92.9 Myeloid leukaemia, unspecified
0.000 0.880 0.120
E34.9 Endocrine disorder, unspecified
0.001 0.882 0.116
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.884 0.116
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.887 0.112
E16.2 Hypoglycaemia, unspecified
0.000 0.888 0.112
C95.0 Acute leukaemia of unspecified cell type
0.000 0.888 0.111
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.889 0.111
E27.2 Addisonian crisis
0.000 0.889 0.110
C91.9 Lymphoid leukaemia, unspecified
0.000 0.893 0.107
C92.4 Acute promyelocytic leukaemia
0.000 0.894 0.106
C92.7 Other myeloid leukaemia
0.000 0.898 0.102
E14.9 Without complications
0.000 0.899 0.101
C83.0 Small cell (diffuse)
0.000 0.905 0.095
E53.8 Deficiency of other specified B group vitamins
0.000 0.907 0.093
H00 Hordeolum and chalazion
0.092 0.908 0.000
C84.4 Peripheral T-cell lymphoma
0.000 0.908 0.091
C91.5 Adult T-cell leukaemia
0.000 0.909 0.090
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.910 0.090
C91.7 Other lymphoid leukaemia
0.000 0.910 0.090
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.910 0.090
C91.3 Prolymphocytic leukaemia
0.000 0.910 0.090
C91.2 Subacute lymphocytic leukaemia
0.000 0.910 0.090
L43 Lichen planus
0.081 0.918 0.001
C62.9 Testis, unspecified
0.082 0.918 0.000
E27.8 Other specified disorders of adrenal gland
0.001 0.920 0.079
H00.0 Hordeolum and other deep inflammation of eyelid
0.080 0.920 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.002 0.923 0.075
K50.0 Crohn's disease of small intestine
0.076 0.924 0.000
C91.4 Hairy-cell leukaemia
0.000 0.926 0.074
K60.1 Chronic anal fissure
0.000 0.930 0.070
C91.0 Acute lymphoblastic leukaemia
0.000 0.932 0.067
K50 Crohn's disease [regional enteritis]
0.065 0.935 0.000
K50.8 Other Crohn's disease
0.065 0.935 0.000
M35.3 Polymyalgia rheumatica
0.000 0.939 0.061
L43.3 Subacute (active) lichen planus
0.058 0.941 0.001
L43.2 Lichenoid drug reaction
0.058 0.941 0.001
L43.1 Bullous lichen planus
0.058 0.941 0.001
L43.0 Hypertrophic lichen planus
0.058 0.941 0.001
N05.2 Diffuse membranous glomerulonephritis
0.000 0.941 0.059
E04 Other non-toxic goitre
0.000 0.941 0.058
N05 Unspecified nephritic syndrome
0.000 0.942 0.058
C90.1 Plasma cell leukaemia
0.001 0.942 0.056
N05.9 Unspecified
0.000 0.943 0.057
K50.1 Crohn's disease of large intestine
0.055 0.945 0.000
C92.0 Acute myeloid leukaemia
0.000 0.945 0.055
C90.3 Solitary plasmacytoma
0.001 0.947 0.052
Z51.3 Blood transfusion without reported diagnosis
0.000 0.947 0.053
E83 Disorders of mineral metabolism
0.046 0.948 0.006
E55.9 Vitamin D deficiency, unspecified
0.000 0.949 0.051
K90-K93 Other diseases of the digestive system
0.000 0.949 0.051
N05.1 Focal and segmental glomerular lesions
0.000 0.950 0.050
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.952 0.048
L43.8 Other lichen planus
0.046 0.953 0.001
E04.8 Other specified non-toxic goitre
0.000 0.958 0.042
N05.6 Dense deposit disease
0.000 0.958 0.041
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.958 0.041
N05.0 Minor glomerular abnormality
0.000 0.958 0.041
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.960 0.040
E83.9 Disorder of mineral metabolism, unspecified
0.036 0.960 0.004
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
0.040 0.960 0.000
N05.8 Other
0.000 0.962 0.038
N05.7 Diffuse crescentic glomerulonephritis
0.000 0.962 0.038
E83.8 Other disorders of mineral metabolism
0.033 0.962 0.005
E83.2 Disorders of zinc metabolism
0.033 0.962 0.005
E83.0 Disorders of copper metabolism
0.033 0.962 0.005
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.963 0.037
E04.0 Non-toxic diffuse goitre
0.000 0.965 0.035

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.